Intuitive Surgical, Inc. $ISRG Shares Purchased by National Pension Service

National Pension Service grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.3% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 705,045 shares of the medical equipment provider’s stock after acquiring an additional 22,468 shares during the quarter. National Pension Service’s holdings in Intuitive Surgical were worth $315,317,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of ISRG. Vanguard Group Inc. grew its stake in Intuitive Surgical by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock worth $18,115,025,000 after buying an additional 670,302 shares during the last quarter. State Street Corp grew its position in Intuitive Surgical by 1.2% in the 2nd quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock valued at $8,451,223,000 after buying an additional 182,871 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 1.4% in the second quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock valued at $4,429,590,000 after acquiring an additional 109,904 shares in the last quarter. Norges Bank purchased a new stake in Intuitive Surgical in the 2nd quarter valued at approximately $2,569,260,000. Finally, Invesco Ltd. grew its holdings in Intuitive Surgical by 4.8% during the second quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider’s stock worth $2,402,488,000 after acquiring an additional 201,159 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, SVP Mark Brosius sold 464 shares of the firm’s stock in a transaction on Monday, December 15th. The stock was sold at an average price of $548.49, for a total transaction of $254,499.36. Following the transaction, the senior vice president directly owned 131 shares in the company, valued at $71,852.19. This trade represents a 77.98% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Henry L. Charlton sold 13,731 shares of the firm’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the transaction, the executive vice president owned 3,056 shares in the company, valued at approximately $1,772,480. The trade was a 81.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 75,683 shares of company stock worth $42,066,425. Company insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of research analyst reports. Piper Sandler reaffirmed an “overweight” rating and issued a $620.00 target price (up from $610.00) on shares of Intuitive Surgical in a report on Friday, January 23rd. Daiwa Capital Markets upped their price objective on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research report on Friday, October 24th. Argus raised their target price on shares of Intuitive Surgical from $600.00 to $630.00 in a research report on Monday, October 27th. Robert W. Baird decreased their price target on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a research note on Friday, January 23rd. Finally, Sanford C. Bernstein lifted their price target on shares of Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a report on Friday, January 23rd. Two research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $620.41.

Intuitive Surgical Trading Down 0.7%

ISRG opened at $504.22 on Friday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $609.08. The firm has a market cap of $180.75 billion, a price-to-earnings ratio of 63.91, a PEG ratio of 3.92 and a beta of 1.67. The company has a fifty day simple moving average of $558.64 and a 200 day simple moving average of $511.63.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter in the prior year, the business posted $2.21 earnings per share. Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. On average, analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.